KZR - Kezar Life Sciences, Inc.
6.475
0.235 3.629%
Share volume: 789
Last Updated: Wed 05 Feb 2025 12:00:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.19%
PREVIOUS CLOSE
CHG
CHG%
$6.24
0.24
3.77%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-09 | 2024-08-13 | 2024-11-12 | |
| Cash flow financing | 0.000 | 56.000 K | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.454 M | -4.759 M | 0.000 | |
| Net income | -21.658 M | -21.547 M | -20.313 M | |
| Depreciation | 260.000 K | 261.000 K | 260.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 20.408 M | 12.216 M | 24.060 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 18.000 K | |
| Cash Change | -2.461 M | -4.756 M | 6.582 M |